Chen, J.; Gao, L.; Liang, Y.; Zhou, W.; Wang, Y.; Wang, X.; Fang, X.; Shao, X.
Synergistic Anti-Tumor Activity of LRPPRC Inhibition and Dasatinib Through Dual Oxidative Phosphorylation Disruption. Pharmaceuticals 2026, 19, 472.
https://doi.org/10.3390/ph19030472
AMA Style
Chen J, Gao L, Liang Y, Zhou W, Wang Y, Wang X, Fang X, Shao X.
Synergistic Anti-Tumor Activity of LRPPRC Inhibition and Dasatinib Through Dual Oxidative Phosphorylation Disruption. Pharmaceuticals. 2026; 19(3):472.
https://doi.org/10.3390/ph19030472
Chicago/Turabian Style
Chen, Jing, Lu Gao, Yuxin Liang, Wei Zhou, Yong Wang, Xiaojia Wang, Xiaohong Fang, and Xiying Shao.
2026. "Synergistic Anti-Tumor Activity of LRPPRC Inhibition and Dasatinib Through Dual Oxidative Phosphorylation Disruption" Pharmaceuticals 19, no. 3: 472.
https://doi.org/10.3390/ph19030472
APA Style
Chen, J., Gao, L., Liang, Y., Zhou, W., Wang, Y., Wang, X., Fang, X., & Shao, X.
(2026). Synergistic Anti-Tumor Activity of LRPPRC Inhibition and Dasatinib Through Dual Oxidative Phosphorylation Disruption. Pharmaceuticals, 19(3), 472.
https://doi.org/10.3390/ph19030472